PLXP - ディペクシウム・ファ―マシュ―ティカルズ （PLx Pharma Inc.） ディペクシウム・ファ―マシュ―ティカルズPLXPのチャート
PLXPの企業情報
| symbol | PLXP |
|---|---|
| 会社名 | PLx Pharma Inc （ディペクシウム・ファ―マシュ―ティカルズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 PLx Pharma Inc. formerly Dipexium Pharmaceuticals Inc. is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system Aspertec 325 mg PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids such as phospholipids and free fatty acids to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen PL1200 Ibuprofen Capsules 200 mg. ディペクシウム・ファ―マシュ―ティカルズは、米国の製薬会社。糖尿病性足部潰瘍の軽度な感染症治療のために、「Locilex(ペキシガナン酢酸クリ―ム0.8％)」を開発、商品化に注力する。「Locilex」は、アフリカツメガエルの皮膚から取られ、化学的に合成された22アミノ酸ペプチドであり、後期の臨床段階にある。 PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with aspirin and ibuprofen, and potentially other drugs. |
| 本社所在地 | 8285 El Rio Street Ste. 130 Houston TX 77054 USA |
| 代表者氏名 | Rita M. O Connor リタ・M・O・コナー |
| 代表者役職名 | Chief Financial Officer |
| 電話番号 | +1 713-842-1249 |
| 設立年月日 | 40179 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2014年 |
| 従業員数 | 14人 |
| url | www.plxpharma.com |
| nasdaq_url | https://www.nasdaq.com/symbol/plxp |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -13.45220 |
| 終値（lastsale） | 4.15 |
| 時価総額（marketcap） | 36253827.3 |
| 時価総額 | 時価総額（百万ドル） 32.23533 |
| 売上高 | 売上高（百万ドル） 0.65163 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 21.37565 |
| 当期純利益 | 当期純利益（百万ドル） -10.30847 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 PLx Pharma Inc revenues decreased 34% to $249K. Net income totaled $1.4M vs. loss of $3.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net Income reflects Change in fair value of warrant liabilit increase from $1.7M to $7.4M (income) Interest and other expense decrease of 23% to $559K (expense). |
PLXPのテクニカル分析
PLXPのニュース
Abnormal volume spikes: Atossa Therapeutics, Inc. (NASDAQ:ATOS), PLx Pharma Inc. (NASDAQ:PLXP) 2023/02/21 14:32:57 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Abnormal volume spikes: Atossa Therapeutics, Inc. (NASDAQ:ATOS), PLx Pharma Inc. (NASDAQ:PLXP) appeared first on Stocks Equity .
Vamping stocks: Atossa Therapeutics, Inc. (NASDAQ:ATOS -0.80%), PLx Pharma Inc. (NASDAQ:PLXP 0.18%) 2023/02/21 12:56:56 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Vamping stocks: Atossa Therapeutics, Inc. (NASDAQ:ATOS -0.80%), PLx Pharma Inc. (NASDAQ:PLXP 0.18%) appeared first on Stocks Equity .
A stock that deserves closer examination: PLx Pharma Inc. (PLXP) 2023/02/01 15:08:00 US Post News
As of Tuesday, PLx Pharma Inc.’s (NASDAQ:PLXP) stock closed at $0.25, up from $0.24 the previous day. While PLx Pharma Inc. has overperformed by 0.91%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PLXP fell by -95.71%, with highs and lows ranging from $6.66 to $0.13, […]
Active Stock’s Momentum: PLx Pharma Inc. (NASDAQ:PLXP -11.62%), Vascular Biogenics Ltd. (NASDAQ:VBLT 4.04%) 2023/01/25 12:26:58 Stock Equity
PLx Pharma Inc. (NASDAQ:PLXP) with the stream of -11.62% also noticed, India Vascular Biogenics Ltd. (NASDAQ:VBLT) encountered a rapid change of 4.04% in the last hour of Tuesday’s trading session. … The post Active Stock’s Momentum: PLx Pharma Inc. (NASDAQ:PLXP -11.62%), Vascular Biogenics Ltd. (NASDAQ:VBLT 4.04%) appeared first on Stocks Equity .
Why Did PLx Pharma Inc. (NASDAQ: PLXP) Drop So Much? 2023/01/24 12:30:00 Stocks Register
PLx Pharma Inc. (NASDAQ:PLXP) traded at $0.28 at close of the session on Monday, 01/23/23, made a downward move of -4.14% on its previous day’s price. Looking at the stock we see that its previous close was $0.29 and the beta (5Y monthly) reads 3.90 with the day’s price range being $0.2705 – $0.3077. In … Why Did PLx Pharma Inc. (NASDAQ: PLXP) Drop So Much? Read More »
Looking Into PLx Pharma''s Return On Capital Employed 2022/09/09 14:11:27 Benzinga
PLx Pharma (NASDAQ: PLXP ) brought in sales totaling $483 thousand during Q2 according to data provided by Benzinga Pro . However, earnings decreased 9.95%, resulting in a loss of $11.86 million. PLx Pharma collected $2.08 million in revenue during Q1, but reported earnings showed a $10.79 million loss. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and … Full story available on Benzinga.com
Delighting stocks: Syros Pharmaceuticals, Inc. (NASDAQ:SYRS -9.93%), PLx Pharma Inc. (NASDAQ:PLXP -8.53%) 2022/09/07 01:17:34 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Delighting stocks: Syros Pharmaceuticals, Inc. (NASDAQ:SYRS -9.93%), PLx Pharma Inc. (NASDAQ:PLXP -8.53%) appeared first on Stocks Equity .
PLXP (PLx Pharma Inc.) has impressive results 2022/08/30 12:00:00 US Post News
A share of PLx Pharma Inc. (NASDAQ:PLXP) closed at $0.99 per share on Monday, up from $0.91 day before. While PLx Pharma Inc. has overperformed by 8.79%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PLXP fell by -94.48%, with highs and lows ranging from $21.19 […]
Spellbinding stocks: NLS Pharmaceutics AG (NASDAQ:NLSP -15.10%), PLx Pharma Inc. (NASDAQ:PLXP -2.93%) 2022/08/25 01:50:45 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Spellbinding stocks: NLS Pharmaceutics AG (NASDAQ:NLSP -15.10%), PLx Pharma Inc. (NASDAQ:PLXP -2.93%) appeared first on Stocks Equity .
Stupefying stocks: GoHealth, Inc. (NASDAQ:GOCO -1.20%), PLx Pharma Inc. (NASDAQ:PLXP -9.57%) 2022/08/22 00:51:35 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Stupefying stocks: GoHealth, Inc. (NASDAQ:GOCO -1.20%), PLx Pharma Inc. (NASDAQ:PLXP -9.57%) appeared first on Stocks Equity .
Benzinga''s Top Ratings Upgrades, Downgrades For December 7, 2021 2021/12/07 15:03:06 Benzinga
Upgrades For CarMax Inc (NYSE: KMX ), JP Morgan upgraded the previous rating of Neutral to Overweight. For the second quarter, CarMax had an EPS of $1.72, compared to year-ago quarter EPS of $1.79. The stock has a 52-week-high of $155.98 and a 52-week-low of $90.30. At the end of the last trading period, CarMax closed at $144.50. According to Evercore ISI Group, the prior rating for RPM International Inc (NYSE: RPM ) was changed from In-Line to Outperform. In the first quarter, RPM International showed an EPS of $1.08, compared to $1.44 from the year-ago quarter. The current stock performance of RPM International shows a 52-week-high of $99.30 and a 52-week-low of $76.43. Moreover, at the end of the last trading period, the closing price was at $95.43. According to Evercore ISI Group, the prior rating for PPG Industries Inc (NYSE: PPG ) was changed from In-Line to Outperform. In the third quarter, PPG Industries showed an EPS of $1.69, compared to $1.93 from the year-ago quarter. The stock has a 52-week-high of $182.97 and a 52-week-low of $132.10.
PLx Pharma Inc. to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 2021/11/22 14:15:00 Intrado Digital Media
SPARTA, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (PLx or the Company) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products VAZALORE 325 mg and VAZALORE 81 mg liquid-filled aspirin capsules (referred to together as VAZALORE), announced today that Natasha Giordano, President and Chief Executive Officer, and Rita OConnor, Chief Financial Officer, are scheduled to present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021.
PLx Pharma Inc. (PLXP): At $10.07, Its Worth Your Attention 2021/11/20 16:30:00 Stocks Register
PLx Pharma Inc. (NASDAQ:PLXP) price on Friday, November 19, fall -3.36% below its previous days close as a downside momentum from buyers pushed the stocks value to $10.07. A look at the stocks price movement, the close in the last trading session was $10.42, moving within a range at $10.02 and $10.70. The beta value PLx Pharma Inc. (PLXP): At $10.07, Its Worth Your Attention Read More »
PLx Pharma Inc. Expected to Post FY2021 Earnings of ($1.63) Per Share (NASDAQ:PLXP) 2021/11/19 07:02:42 Dakota Financial News
PLx Pharma Inc. (NASDAQ:PLXP) Equities researchers at BWS Financial reduced their FY2021 earnings per share estimates for shares of PLx Pharma in a note issued to investors on Monday, November 15th. BWS Financial analyst H. Khorsand now expects that the biotechnology company will post earnings per share of ($1.63) for the year, down from []